Angela Moore

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy

Gábor Barcs, Edwin Walker, Christian E. Elger et al. · Epilepsia · 2000 · 225 citations

Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies

Joseph F. Fowler, Michael Jarratt, Angela Moore et al. · British Journal of Dermatology · 2011 · 164 citations · Full text

A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis

Angela Moore, Kenneth B. Gordon, Sewon Kang et al. · Journal of the American Academy of Dermatology · 2006 · 156 citations

Open-label Trial, Continuous Versus, Medicine +9

Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.

Joseph F. Fowler, Mark Jackson, Angela Moore et al. · PubMed · 2013 · 122 citations